Co-Diagnostics signs MoU with partner in Kingdom of Saudi Arabia

Group 1 - Co-Diagnostics (CODX) has signed a strategic Memorandum of Understanding (MOU) with a regional manufacturing and distribution company in Saudi Arabia to explore a joint venture [1] - The joint venture will be licensed to develop, manufacture, and sell Co-Dx intellectual property across the Middle East and North Africa, including the upcoming Co-Dx PCR point-of-care platform [1] - The Saudi partner will provide local operational support, access to infrastructure, personnel, regulatory expertise, and other critical resources for the joint venture's objectives [1]